HMGB1 protein inhibitorsand/or antagonists for the treatment...

Details HMGB1 protein inhibitorsand/or antagonists for the treatment... HMGB1 protein inhibitorsand/or antagonists for the treatment...

2008-01-02

2011-11-15

Skelding, Zachary (Department: 1644)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S007900

Reexamination Certificate

active

08058239

ABSTRACT:
The use of HMG box-binding molecules and molecules having sequence homology with HMG box for the preparation of therapeutic agents for the treatment of vascular diseases is described.

REFERENCES:
patent: 6054122 (2000-04-01), MacPhee et al.
patent: WO 9726913 (1997-07-01), None
patent: WO 9739121 (1997-10-01), None
patent: WO 9739125 (1997-10-01), None
patent: WO9822138 (1998-05-01), None
patent: WO0047104 (2000-08-01), None
patent: WO0076573 (2000-12-01), None
patent: WO 2006008779 (2006-01-01), None
Parkkinen et al., J Biol Chem. Sep. 15, 1993;268(26):19726-38.
Rauvala et al., Matrix Biol. Sep. 2000;19(5):377-87.
Pins et al., J Invest Dermatol. Apr. 2000;114(4):647-53.
Bear et al., Cell, vol. 101, 717-728, Jun. 23, 2000.
Fawcett et al., The Journal of Cell Biology, vol. 128, 1995, pp. 1229-1241.
Wells, 1990, Biochemistry 29:8509-8517.
Ngo et al., 1994, The Protein Folding Problem and Tertiary Structure Prediction, pp. 492-495.
Bork, 2000, Genome Research 10:398-400.
Skolnick et al., 2000, Trends in Biotech. 18(1):34-39, especially p. 36 at Box 2.
Doerks et al., 1998, Trends in Genetics 14:248-250.
Smith et al., 1997, Nature Biotechnology 15:1222-1223.
Brenner, 1999, Trends in Genetics 15:132-133.
Bork et al., 1996, Trends in Genetics 12:425-427.
Andersson et al., 2000 J. Exp. Med., vol. 192 565-70.
Chen et al., 2004. J Interferon and Cylokine Res. vol. 24: 329-33.
Degryse, B et al. The High Mobility Group HMG Boxes of the Nuclear Protein HMG1 Induce Chemotaxis and Cytoskeleton Reorganization in Rat Smooth Muscle Cells. J Cell Biol. 152, 1197-1206 (2001).
Hertel L et al. Decreased Expression of the High Mobility Group Protein T160 by Antisense RNA Impairs the Grwoth of Mouse Fibroblasts. Biochimie 79, 717-723 (1997).
Ronfani L et al Reduced Fertility and Spermatogenesis Defedts in Mice Lacking Chromosomal Protein HMGB2 Development 128, 1265-1273 (2001).
Stros M et al., A Role of Basic Residues and the Putative Intercalating Phenylalanine of the HMG1 Box B in DNA Supoercoiling and Binding to Four Way DNA Junctions. J Biol Chem 275(46), 35699-35707 (2000).
Yamazaki, F et al Repression of Cell Cycle Progression by Antigsense HMG2 RNA, Biochem. Biophys. Res. Comm 210(2), 1045-1051(1995).
PCT/IT02/00153, Intr Search Rpt.

Affiliated with

Also associated with

Rating

HMGB1 protein inhibitorsand/or antagonists for the treatment... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with HMGB1 protein inhibitorsand/or antagonists for the treatment..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and HMGB1 protein inhibitorsand/or antagonists for the treatment... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4281163